These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Type B thymoma: is prognosis predicted only by World Health Organization classification? Kim HK, Choi YS, Kim J, Shim YM, Han J, Kim K. J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1431-1435.e1. PubMed ID: 20038470 [Abstract] [Full Text] [Related]
9. Long-term survival and prognostic factors in thymic epithelial tumours. Rea F, Marulli G, Girardi R, Bortolotti L, Favaretto A, Galligioni A, Sartori F. Eur J Cardiothorac Surg; 2004 Aug; 26(2):412-8. PubMed ID: 15296907 [Abstract] [Full Text] [Related]
10. World Health Organization classification of thymomas provides significant prognostic information for selected stage III patients: evidence from an international thymoma study group. Marchevsky AM, Gupta R, Casadio C, Hiroshima K, Jambhekar NA, Kim DJ, Nakatani Y, Okumura M, Rena O, Yoshida S. Hum Pathol; 2010 Oct; 41(10):1413-21. PubMed ID: 20573368 [Abstract] [Full Text] [Related]
11. Thymoma: prognostic factors and treatment outcomes. Gripp S, Hilgers K, Wurm R, Schmitt G. Cancer; 1998 Oct 15; 83(8):1495-503. PubMed ID: 9781943 [Abstract] [Full Text] [Related]
12. The correlation of the World Health Organization histologic classification of thymic epithelial tumors and its prognosis: a clinicopathologic study of 108 patients from China. Honglin Yin, Jun Du, Zhenfeng Lu, Xia Jiao, Jiandong Wang, Xiaojun Zhou. Int J Surg Pathol; 2009 Jun 15; 17(3):255-61. PubMed ID: 19443889 [Abstract] [Full Text] [Related]
13. Masaoka staging is of prognostic relevance in type B3 / C thymomas. Luebke T, Beckurts KT, Wickenhauser C, Schneider P, Hoelscher AH, Moenig SP. Anticancer Res; 2004 Jun 15; 24(6):4113-9. PubMed ID: 15736461 [Abstract] [Full Text] [Related]
14. A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features. Kim BK, Cho BC, Choi HJ, Sohn JH, Park MS, Chang J, Kim SK, Kim DJ, Chung KY, Lee CG, Kim JH, Yoo NC. Oncol Rep; 2008 Jun 15; 19(6):1525-31. PubMed ID: 18497960 [Abstract] [Full Text] [Related]
15. [Surgery for thymomas and thymic carcinomas; treatment results in terms of WHO histologic typing, Masaoka staging system, and p53 expression]. Yamazaki K, Kitada M, Sasaki K, Koshiko S, Hirasawa M, Ozawa K, Kajiura Y, Sasajima T, Miyokawa N. Kyobu Geka; 2002 Oct 15; 55(11):949-52. PubMed ID: 12391691 [Abstract] [Full Text] [Related]
16. [Clinical outcome of epithelial tumors of the thymus]. Tsukada H, Koike J, Osada H. Kyobu Geka; 2002 Oct 15; 55(11):936-41. PubMed ID: 12391689 [Abstract] [Full Text] [Related]
17. Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. D'Angelillo RM, Trodella L, Ramella S, Cellini N, Balducci M, Mantini G, Cellini F, Ciresa M, Fiore M, Evoli A, Sterzi S, Russo P, Grozio A, Cesario A, Granone P. Int J Radiat Oncol Biol Phys; 2008 Jun 01; 71(2):420-7. PubMed ID: 18164843 [Abstract] [Full Text] [Related]
18. Expression of podoplanin in thymoma: its correlation with tumor invasion, nodal metastasis, and poor clinical outcome. Tateyama H, Sugiura H, Yamatani C, Yano M. Hum Pathol; 2011 Apr 01; 42(4):533-40. PubMed ID: 21237498 [Abstract] [Full Text] [Related]
19. [Is the microscopic morphology of thymoma of clinical significance?]. Szołkowska M, Langfort R, Roszkowski-Sliz K. Pneumonol Alergol Pol; 2005 Apr 01; 73(2):153-9. PubMed ID: 16756145 [Abstract] [Full Text] [Related]
20. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3? Laeng RH, Eimoto T, Kuo TT, Zettl A, Marx A, Moschopulos M, Tateyama H, Shimokawa K. Pathol Res Pract; 2006 Apr 01; 202(10):697-704. PubMed ID: 16887284 [Abstract] [Full Text] [Related] Page: [Next] [New Search]